Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Encourages 'Established Conditions' Use Despite ICH Q12 Uncertainty

Oct 04 2016

• By Bowman Cox

Related Content

FDA Would Establish Conditions for Swift Manufacturing Changes

Jun 25 2015

ICH Q12 Experts Develop Four-Tier Scheme For Harmonizing Post-Approval Changes

Aug 09 2016

Additional Topics

Manufacturing Quality BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window